- Betamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Betamethasone 0.1% / Neomycin 0.5% ear/eye/nose drops | Start Date 25-06-2010 | End Date |
Previous Name | Previous Name Neomycin 0.5% / Betamethasone 0.1% ear/eye/nose drops | Start Date 03-12-2002 |
End Date
|
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Ocular, Auricular, Nasal
- Form
- Ear/eye/nose drops solution
- Ontology Form/Route
- solutiondrops.ophthalmic, solutiondrops.auricular, solutiondrops.nasal
- Name Basis
- Other
Codes
- ATC Code
- S03CA06
BNF | Start Date | End Date |
---|---|---|
Current BNF 12010100 | Start Date 04-04-2022 | End Date |
Previous BNF 12020300 | Start Date 23-02-2005 | End Date 03-04-2022 |
Previous BNF 11040100 | Start Date 15-02-2005 | End Date 03-04-2022 |
Previous BNF 12010100 | Start Date 15-02-2005 | End Date 03-04-2022 |
Code | Start Date | End Date |
---|---|---|
42185211000001105 | 25-08-2023 | |
330953008 | 03-12-2002 | 24-08-2023 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Betamethasone sodium phosphate | Based on Base Substance | Betamethasone | 1 mg | 1 ml |
Neomycin sulfate | Based on Ingredient Substance | 5 mg | 1 ml |
Name
Neomycin sulfate
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
5
Strength and UOM (Dmr)
1
Name
Betamethasone sodium phosphate
Basis of strength description
Based on Base Substance
BOSS
Betamethasone
Strength and UOM (Nmr)
1
Strength and UOM (Dmr)
1
Parent Products
-
VTMBetamethasone + Neomycin
-
VMP(Current) Betamethasone 0.1% / Neomycin 0.5% e...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
5 ml | ||
10 ml | 239 | Part VIIIA Category C |